Clinical trial
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
NCT00266240 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00266240 |
|---|---|
| Title | A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus |
| Official title | A Randomized, Double-blind Study to Determine the Effect of GK Activator (2) on Efficacy (HbA1c), Safety, Tolerability and Pharmacokinetics in Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus Type 2 |
| Intervention type | Drug |
| Interventions | GK Activator (2), Placebo |
| Enrollment | 267 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Dec 16, 2005 |
| Last update posted | Nov 2, 2016 |
| Countries | Bulgaria, Croatia, Guatemala, Hungary, Mexico, Poland, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: